AST
Asterias Biotherapeutics Inc. Series A
AST
AST
Delisted
AST was delisted on the 7th of March, 2019.
64 hedge funds and large institutions have $35.6M invested in Asterias Biotherapeutics Inc. Series A in 2016 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 20 increasing their positions, 10 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
Holders
64
Holding in Top 10
1
Calls
$208K
Puts
–
Top Buyers
| 1 | +$2.96M | |
| 2 | +$678K | |
| 3 | +$442K | |
| 4 |
State Street
Boston,
Massachusetts
|
+$254K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$247K |
Top Sellers
| 1 | -$741K | |
| 2 | -$61K | |
| 3 | -$53K | |
| 4 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
-$34K |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$28.4K |